Oncotarget

Vol 11, No 39

September 29, 2020

View Archive »

Order a Reprint

About The Cover

The cover for issue 39 of Oncotarget features Figure 4, "Apoptosis assay of NRXN1-targeted ADC at IC50 dose calculated by growth inhibition curves," by Yotsumoto, et al.

Table of Contents

Editorial

Minority MOMP: a toxic, slow demise

Minority MOMP: a toxic, slow demise

https://doi.org/10.18632/oncotarget.27753

Yuan Xu, Deborah R. Surman,  and R. Taylor Ripley
3559-3561
PDF  |  How to cite  |  Order a Reprint

Research Perspectives

Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential

Ferroptosis of epithelial ovarian cancer: genetic determinants and therapeutic potential

https://doi.org/10.18632/oncotarget.27749

Chao-Chieh Lin,  and Jen-Tsan Chi
3562-3570
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

Research Papers

Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy

Targeted lymphodepletion with a CD45-directed antibody radioconjugate as a novel conditioning regimen prior to adoptive cell therapy

https://doi.org/10.18632/oncotarget.27731

Wojciech Dawicki, Kevin J.H. Allen, Ravendra Garg, Eileen M. Geoghegan, Mark S. Berger, Dale L. Ludwig,  and Ekaterina Dadachova
3571-3581
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Order a Reprint

PD-1/PD-L1 expression in anal squamous intraepithelial lesions

PD-1/PD-L1 expression in anal squamous intraepithelial lesions

https://doi.org/10.18632/oncotarget.27756

Margot Bucau, Nathalie Gault, Nanthara Sritharan, Emy Valette, Charlotte Charpentier, Francine Walker, Anne Couvelard,  and Laurent Abramowitz
3582-3589
Abstract  |  PDF  |  Full Text  |  How to cite  |  Order a Reprint

NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

NRXN1 as a novel potential target of antibody-drug conjugates for small cell lung cancer

https://doi.org/10.18632/oncotarget.27718

Takuma Yotsumoto, Keita Maemura, Kousuke Watanabe, Yosuke Amano, Yoko Matsumoto, Koichi Zokumasu, Takahiro Ando, Masanori Kawakami, Hidenori Kage, Jun Nakajima, Yutaka Yatomi, Takahide Nagase,  and Daiya Takai
3590-3600
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Press Release  |  Podcast  |  Order a Reprint

Meta-Analysis

Meta-analysis of gene expression profiling reveals novel basal gene signatures in MCF-10A cells transformed with cadmium

Meta-analysis of gene expression profiling reveals novel basal gene signatures in MCF-10A cells transformed with cadmium

https://doi.org/10.18632/oncotarget.27734

Katrina Blommel, Carley S. Knudsen, Kyle Wegner, Swojani Shrestha, Sandeep K. Singhal, Aaron A. Mehus, Scott H. Garrett, Sonalika Singhal, Xudong Zhou, Brent Voels, Donald A. Sens,  and Seema Somji
3601-3617
Abstract  |  PDF  |  Full Text  |  Supplementary Information  |  How to cite  |  Order a Reprint

Corrections

Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity

Correction: Co-targeting the MAPK and PI3K/AKT/mTOR pathways in two genetically engineered mouse models of schwann cell tumors reduces tumor grade and multiplicity

https://doi.org/10.18632/oncotarget.27349

Adrienne L. Watson, Bryant J. Keller, Kyle A. Williams, Namrata N. Damle, Samuel J. Finnerty, Leah K. Anderson, Andrew D. Greeley, Vincent W. Keng, Eric P. Rahrmann, Amanda L. Halfond, Natasha M. Powell, Margaret H. Collins, Tilat Rizvi, Christopher L. Moertel, Nancy Ratner,  and David A. Largaespada
3618-3620
Correction  |  PDF  |  How to cite


Copyright © 2020 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC